Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Individual results vary based on genetics, adherence, diet, and exercise
Government regulations involving drug approvals, clinical trials, safety standards, and healthcare reimbursement policies continue shaping market development globally
If you are exercising, living in a hot climate, or experiencing other GI side effects like diarrhea or vomiting, your needs will be higher
Monitoring of volume status and renal parameters is advisable Poorly controlled hypertension , where the interaction between retatrutide and existing antihypertensive regimens may be unpredictable A history of pancreatitis : in line with UK Summary of Product Characteristics (SmPC) wording for approved GLP-1-based therapies such as semaglutide (Wegovy) and tirzepatide (Mounjaro), retatrutide should be used with caution in patients with a history of pancreatitis, and discontinued promptly if acute pancreatitis is suspected Thyroid C-cell tumours : rodent studies with GLP-1 receptor agonists have identified C-cell hyperplasia and tumours
They can recommend the right product and dosage for your needs and ensure it won't interfere with your medication or cause other GI side effects
US$ 27.57
US$ 28.43
US$ 27.78
US$ 24.25
US$ 28.27
US$ 21.24
US$ 20.17
US$ 24.06
US$ 29.58
